|Mr. Irwin D. Simon||CEO & Chairman||6.54M||N/A||1959|
|Mr. Carl A. Merton||Chief Financial Officer||809k||740.72k||N/A|
|Dr. Christelle Gedeon L.L.B., Ph.D.||Chief Legal Officer & Corp. Sec.||962k||N/A||N/A|
|Mr. James R. Meiers||Chief Operating Officer of Aphria Leamington||751.87k||N/A||N/A|
|Ms. Denise Menikheim Faltischek||Chief Strategy Officer & MD of Aphria Germany||562.35k||N/A||1973|
|Mr. John B. Sadler||VP of Investor Relations||N/A||N/A||N/A|
|Mr. Bernard Yeung||Sr. VP of Sales & Marketing||N/A||N/A||N/A|
|Mr. Victor Neufeld||Special Advisor||N/A||N/A||1954|
|Mr. Cole Cacciavillani||Special Advisor||N/A||N/A||1955|
|Mr. Randy Daigneau||Sr. VP of Supply Chain||N/A||N/A||N/A|
Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.
Aphria Inc.’s ISS Governance QualityScore as of December 3, 2020 is 10. The pillar scores are Audit: 9; Board: 9; Shareholder Rights: 10; Compensation: 10.